Lancet Surgisphere Hydroxychloroquine Study

Click image to zoom

Lancet Surgisphere Hydroxychloroquine Study

The webpage on the medical journal The Lancet of a now-retracted study on anti-malarial drug hydroxychloroquine as treatment for COVID-19 is seen on a mobile phone in Manila, Philippines on Wednesday, 23 September 2020. Leading medical journal The Lancet announced changes to its editorial policy after retracting a study by Surgisphere on the adverse effects of hydroxychloroquine as treatment for COVID-19 after its authors found lapses on the data gathered by the US healthcare analytics company. (Photo Illustration by Richard James Mendoza/NurPhoto)


Photo Details


Usage Guidelines

Editorial Use Only. Commercial use is not permitted without prior authorization.
Contact us for licensing inquiries

Related Keywords

Rights-Managed (RM) · Single Editorial Use

License This Image

Configure usage rights. Price adjusts in real time.

One license covers one publication within the parameters you select. Each additional publication (e.g. separate articles, posts, issues) requires its own license. License terms ›

Media Type
Image Size
License Duration
Territory
Page Placement
Monthly Page Views
Print Run / Circulation
Need custom or commercial rights? Contact Sales · [email protected]
2026 NurPhoto. All rights reserved. This image is the property of NurPhoto and is protected under international copyright laws.